4//SEC Filing
Albertson Tina M. 4
Accession 0001209191-23-013848
CIK 0001806952other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:19 PM ET
Size
6.2 KB
Accession
0001209191-23-013848
Insider Transaction Report
Form 4
Albertson Tina M.
Chief Medical Officer
Transactions
- Award
Option (right to buy)
2023-02-24+700,000→ 700,000 totalExercise: $2.13Exp: 2033-02-23→ Common Stock (700,000 underlying)
Holdings
- 4,049
Common Stock
Footnotes (2)
- [F1]Includes 2,495 shares acquired on May 18, 2022 and 1,554 shares acquired on November 18, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.
- [F2]12.5% of the option shares shall vest on August 9, 2023, with the remaining option shares to vest in equal monthly installments over the following forty-two months.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001917391
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 6:19 PM ET
- Size
- 6.2 KB